Summary
We report here a case of polymyositis and toxoplasmosis, and review the previous examples of this association. We suggest that in most cases this relationship is due to reactivation of latent infection in an immunocompromised host. Gross immunological aberrations underline the pathogenesis of polymyositis and these predispose the patient to the development of toxoplasmosis. Anti-protozoal therapy is necessary and produces some clinical benefit, but it does not cure the polymyositis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Beattie CP (1957) Clinical and epidemiological aspects of toxoplasmosis. Trans R Soc Trop Med Hyg 51:96–103
Beattie CP (1967) Toxoplasmosis. In: Waterson AP (ed) Recent advances in medical microbiology. Churchill, London, pp 318–351
Behan WMH, Barkas T, Behan PO (1982a) Detection of immune complexes in polymyositis. Acta Neurol Scand 65:320–334
Behan WMH, Behan PO (1978) HLA-B8 in polymyositis. New Engl J Med 198:1260–1261
Behan WMH, Behan PO (1980) A comparison between human polymyositis and the putative animal model, experimental allergic myositic. In: Rose FC, Behan PO (eds) Animal models of neurological disease. Pitman, Kent, England, pp 72–89
Behan WMH, Behan PO, Doyle D (1982b) Association of myasthenia gravis and polymyositis with neoplasia, infection and autoimmune disorders. Acta Neuropathol (Berl) 57:221–229
Behan WMH, Behan PA, Simpson JA (1975) Absence of cellular hypersensitivity to muscle and thymic antigens in myasthenia gravis. J Neurol Neurosurg Psychiatry 38:1039–1047
Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. New Engl J Med 291:344–347; 292:403–407
Chandar K, Mair HJ, Mair NS (1968) Case of toxoplasma polymyositis. Br Med J 1:158–159
Dick HA, Crichton WB, Ferguson-Smith MA, Isatt MM (1972) Study of the HL-A and other polymorphic systems in a Scottish population. In: Dausset J, Columbart J (eds) Histocompatibility testing. Munksgaard, Copenhagen, p 63
Feldman HA, Schreiber R (1977) Toxoplasmosis dangerous in complement deficiency. New England J Med 297:1403
Gamboa ET, Eastwood AB, Hays AP, Maxwell J, Pen AS (1979) Isolation of influenza virus from muscle in myoglobinuric polymyositis. Neurology 29:1323–1335
Ginsburg BE, Wasserman J, Huldt G, Bergstrand A (1974) Case of glomerulonephritis associated with acute toxoplasmosis. Br Med J 3:664–665
Greenlee JE, Johnson WD, Campa JF, Adelman LS, Sande MA (1975) Adult toxoplasmosis presenting as polymyositis and cerebellar ataxia. Ann Int Med 82:367–371
Hendrickx GFM, Verhage J, Jennekens FGI, Van Knapen F (1979) Dermatomyositis and toxoplasmosis. Ann Neurol 5:393–395
Lisak RP, Barchi RL (1982) Immunology, myasthenia gravis. Saunders, Philadelphia London Toronto, pp 110–156
Herberman RB (1978) In vitro tests of cellular immunity in man. Invest Cell Pathol 1:227–248
Hudgson P, Walton JN (1979) Polymyositis and other inflammatory myopathies. In: Vinckens PJ, Bryn GW (eds) Handbook of clinical neurology, vol 41. North Holland, Amsterdam, pp 51–93
Kagen LJ, Kimball AC, Christian CL (1974) Serologic evidence of toxoplasmosis among patients with polymyositis. Am J Med 56:186–191
Karim KA, Ludlam GB (1975) The relationship and significance of antibody titres as determined by various serological methods in glandular and ocular toxoplasmosis. J Clin Pathol 28:42–49
Kass EH, Andrews SB, Adams RD, Turner FC, Feldman HA (1952) Toxoplasmosis in the human adult. Arch Int Med 87:759–782
Krick JA, Remington JS (1978) Toxoplasmosis in the adult — an overview. New Engl J Med 292:550–553
Leddy JP, Griggs RC, Klemperer MR, Frank MM (1975) Hereditary complement (C2) deficiency with dermatomyositis. Am J Med 58:83–91
Lisak RP, Barchi RL (1982) Immunology, myasthenia gravis. Saunders, Philadelphia London Toronto, pp 110–156
McNicholl B, Underhill D (1970) Toxoplasmic polymyositis. I. J Med Sci 3:525–527
Pachman CM, Johansson O, Cannon RA, Friedman JM (1977) HLA-B8 in juvenile dermatomyositis. Lancet II:567–568
Pauly IL, Sokal JE, Han T (1973) Whole blood culture technique for functional studies of lymphocyte reactivity to mitogens antigens and homologous lymphocytes. J Lab Clin Med 82:500–512
Pearson CM (1975) Myopathy with viral-like structures. New Engl J Med 292:641–642
Pollock JL (1979) Toxoplasmosis appearing to be dermatomyositis. Arch Dermatol 115:736–737
Rowland LP, Greer M (1963) Toxoplasmic polymyositis. Neurology 11:367–370
Ruskin J, Remington JS (1976) Toxoplasmosis in the compromised host. Ann Int Med 84:193–199
Sabin AB, Feldman HA (1948) Dyes as microchemical indicators of a new immunity phenomenon affecting a protozoan parasite (toxoplasma). Science 108:660–663
Samuels BS, Rietschel RL (1976) Polymyositis and toxoplasmosis. JAMA 235:60–61
Soborg M, Bendixen G (1967) Human lymphocyte migration as a parameter of hypersensitivity. Acta Med Scand 181:247–256
Syverton JT, Slavin HB (1946) Human toxoplasmosis. JAMA 131:957–959
Tang TT, Sedmak GV, Siegesmund KA, McCreadie SR (1975) Chronic myopathy associated with coxsackievirus type A9. New Engl J Med 292:608–611
Topi GC, d'Alessandro L, Catricala C, Zardi O (1979) Dermatomyositis-like syndrome due to toxoplasma. Br J Dermatol 101:589–591
Author information
Authors and Affiliations
Additional information
Supported by the Muscular Dystrophy Group of Great Britain
Rights and permissions
About this article
Cite this article
Behan, W.M.H., Behan, P.O., Draper, I.T. et al. Does toxoplasma cause polymyositis?. Acta Neuropathol 61, 246–252 (1983). https://doi.org/10.1007/BF00691993
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00691993